The red grape Vitis vinifera L. (Vitaceae)

its juices and wines in prevention of cardiovacular disorders

Authors

  • Gustavo G. de Souza Centro Universitário Vila Velha
  • Leonardo O. Meneghin Centro Universitário Vila Velh
  • Sandro P. Coelho Centro Universitário Vila Velha
  • June F. Maia Centro Universitário Vila Velha
  • Ary G. da Silva Centro Universitário Vila Velha

Abstract

This is a review paper on the role of resveratrol from red wine in the prevention of cardiovascular disorders. The atherosclerosis etiology is deeply associated with oxygen reactive species, the oxygen free radicals, and with the oxidation of LDL-cholesterol, as indicative agents or participants of several steps of the atherogenic process. Resveratrol is a powerful free-radical scavenger. Wines are composed of water, alcohols sugars, organic acids, proteins and their constitutive micromolecules are poliphenolics, anthocianic pigments, ions and vitamins. The cardioprotector effect of red wine has been attributed to resveratrol. Epidemiological studies had shown a low incidence of cardiovascular disorder risk in France and Greece, what has been associated with a high consumption of red wine. This situation is scientific known as the cardiologic “French Paradox”.

Keywords:

free radicals, polyphenols, atherosclerosis, antioxidants

Downloads

Download data is not yet available.

Author Biographies

June F. Maia, Centro Universitário Vila Velha

Professor Doutor I do curso de Nutrição

Ary G. da Silva, Centro Universitário Vila Velha

Professor Doutor I do curso de Farmácia

References

Alcocer F, Whitley D, Salazar-Gonzalez JF, Jordan WD, Sellers MT, Eckhoff DE, Suzuki K, Macrae C & Bland KI (2002) Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 131: 198-204, 2002.

Auger C, Gérain P, Laurent-Bichon F, Portet K, Bornet A, Caporiccio B, Cros G, Teissédre PL & Rouanet JM (2004) Phenolics from commercialized grape extracts prevent early atherosclerotic lesions in hamsters by mechanisms other than antioxidant effect. Journal of Agriculture and Food Chemistry 52: 5297-5302.

Aviram M & Fuhrman B (2002) Wine flavonoids protect against LDL oxidation and atherosclerosis. Annals of the New York Academy of Sciences 957: 146-161.

Brasileiro FG (1998) Bogliolo patologia geral. 2 ed. Rio de Janeiro: Guanabara Koogan.

Brasileiro FG (1999) Bogliolo patologia geral. 6 ed. Rio de Janeiro: Guanabara Koogan.

Braunwald E (1999) Tratado de medicina cardiovascular 5 ed, Porto Alegre: Artmed, 2v.

Brito P, Almeida LM & Dinis TC (2002) The interaction of resveratrol with ferrylmyoglobin and peroxynitrite, protection against LDL oxidation. Free Radicical Research 36: 621-631.

Bruder JL, Hsieh T, Lerea KM, Olson SC & Wu JM (2001) Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. BMC Cell Biology 2: 1.

Brunello T, Campos T, Chino M, Dammous R, Moretti D, Neri L, Prates A, Araújo T (2001) Uvas e vinhos como alimentos funcionais. NutriMais. Disponível em http:// www.nutrimais.com/nutri/trabalho/uvas_vinhos.asp, acesso em 25.11.2005.

Gaetano G& Cerletti C (2001) Wine and cardiovascular disease. Nutrition, Metabolism & Cardiovascular Diseases 11: 47-50.

Deckert V, Desrumaux C, Athias A, Duverneuil L, Palleau V, Gambert P, Masson D & Lagrost L (2002) Prevention of LDL alfa-tocoferol consumption, cholesterol oxidation, and vascular endothelium dysfunction by polyphenolic compounds from red wine. Atherosclerosis 165: 41-50,.

Faria JL (1999) Patologia especial: com aplicações clinicas. Rio de Janeiro: Guanabara Koogan. 2 ed. 2 v.

Farkas A (1992) Um copo de vinho faz bem ao coração. Revista do Vinho 6: 31.

Folts JD (2002) Potential health benefits from the flavonoids in grape products on vascular disease. Advances in Experimen-tal Medicine and Biology 505: 95-111.

Giannini SD (1998) Aterosclerose e dislipidemia: clínica e terapêutica: fundamentos práticos. São Paulo, BG Cultural.

Ishimoto EY (2003) Atividade antioxidante in vitro em vi-nhos e sucos de uva. Dissertação de Mestrado. Faculdade de Saúde Pública, Universidade de São Paulo. São Paulo.

Kollár P, Kotolová H, Necas J, Karpísek M, Bartosíková L & Karesová P (2000) Experimental study of resveratrol and flavonoids in red wine with regard to their possible hypolipemic effects. Vnitraní Lékaraství 46: 856-860.

Lamuela-Raventos RM & Andres-Lacueva C (2004) Wine in mediterranean diet. Archivos Latinoamericanos de Nutrición 54: 79-82.

Losa GA (2003) Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. European Journal of Clinical Investigation 33: 818-823.

Mendes A, Desgranges C, Chèze C, Vercauteren J & Freslon JL (2003) Vasorelaxant effects of grape polyphenols in rat isolated aorta: possible involvement of a purinergic pathway. Funda-mental & Clinical Pharmacology 17: 673-681.

Miura D, Miura Y & Yagasaki K (2003) Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sciences 73: 1393-1400.

Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H & Gille L (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochemical Pharmacology 69: 903-912.

Pataki T, Bak I, Kovacs P, Bagchi D, Das DK & Tosaki A (2002) Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. American Journal of Clinical Nutrition 75: 894-899.

Pérez DD, Strobel P, Foncea R, Díez MS, Vásquez L, Urquiaga I, Castillo O, Cuevas A, San Martín A & Leighton F (2002) Wine, diet, antioxidant defenses, and oxidative damage. Annals of the New York Academy of Sciences 957: 136-145.

Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E & Böhm M (2002) Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the “French paradox”. Journal of the Federation of American Societies for Experimental Biology 16: 1958-1960.

Russo A, Palumbo M, Aliano C, Lempereur L, Scoto G & Renis M (2003) Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sciences 72: 2369-2379.

Shanmuganayagam D, Beahm MR, Osman HE, Krueger CG, Reed JD & Folts JD (2002) Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans. Journal of Nutrition 132: 3592-3598.

Stocker R & O’halloran RA (2004) Dealcoholized red wine decreases therosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. American Journal of Clinical Nutrition 79: 123-130.

Watzl B, Bub A, Pretzer G, Roser S, Barth SW & Rechkemmer G (2004) Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. European Journal of Clinical Nutrition 58: 40-45.

Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG & Huang YZ (2001) Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. International Journal of Molecular Medicine 8: 3-17.

Zenebe W & Pechanova O (2002) Effects of red wine polyphenolic compounds on the cardiovascular system. Bratislavske Lekarske Listy 103: 159-165.

Zhuang H, Kim YS, Koehler RC & Doré S (2003) Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Annals of the New York Academy of Sciences 993: 276-288.

How to Cite

Souza, G. G. de, Meneghin, L. O., Coelho, S. P., Maia, J. F., & Silva, A. G. da. (2006). The red grape Vitis vinifera L. (Vitaceae): its juices and wines in prevention of cardiovacular disorders. Natureza Online, 4(2), 80–86. Retrieved from https://naturezaonline.com.br/revista/article/view/192

Most read articles by the same author(s)